Korsana
KRSA

Korsana (KRSA) analyst forecast and price target

Analyst forecast

Buy

Consensus of 6 analyst ratings

Buy
6
Hold
0
Sell
0
Average price target
$51.20+44.43% vs. last price
Last $35.45
Low $43.00High $70.00

Based on 5 analyst targets

6 firms have rated Korsana Biosciences (KRSA) in the last 3 months: 6 buy, 0 hold and 0 sell. Their average 12-month price target is $51.20, 53.4% above a share price of $33.38, ranging from $43 (Stifel) to $70 (Guggenheim). No firm has changed its rating in that time.

Recent analyst ratings

Last 3 months
FirmActionRatingPrice targetDate
Wells FargoInitiated CoverageOverweight$44.00Nov 13, 2026
WedbushInitiated CoverageOutperform$44.00Oct 5, 2026
GuggenheimInitiated CoverageBuy$70.00Sep 28, 2026
StifelInitiated CoverageBuy$43.00Sep 14, 2026
TD CowenInitiated CoverageBuy—Sep 14, 2026
UBSInitiated CoverageBuy$55.00Sep 11, 2026

Frequently asked questions

  • What is the price target for KRSA stock?

    The average 12-month analyst price target for Korsana (KRSA) is $51.20, with a high estimate of $70.00 and a low of $43.00, across 5 analysts.

  • Is KRSA a buy, sell, or hold?

    Analysts covering Korsana currently average a Buy rating: 6 buy, 0 hold and 0 sell, from 6 analysts. Ratings reflect analyst opinion, not investment advice.

  • What upside do analysts see for KRSA?

    The average price target of $51.20 implies 44.43% upside from the last price of $35.45.

  • Who has the highest and lowest price target for KRSA?

    Among the price targets analysts have published for Korsana in the last 3 months, the highest is $70.00 from Guggenheim and the lowest is $43.00 from Stifel.

  • Has KRSA been upgraded or downgraded recently?

    No. Korsana has had no analyst upgrades or downgrades in the last 3 months.

  • What is the latest analyst rating on KRSA?

    On Nov 13, 2026, Wells Fargo initiated coverage of Korsana at Overweight with a price target of $44.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.